Quick Answer
DarioHealth Corp. reported Stockholders Equity of $67.92 million for the year ending 2025.
- DarioHealth Corp. showed a decrease of -5.7% in Stockholders Equity from 2024 to 2025.
- This data is from DarioHealth Corp.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2015: -$4.75 million | Q2 2015: -$5.78 million | Q3 2015: -$3.96 million | Q1 2016: $7.61 million | Q2 2016: $5.21 million | Q3 2016: $4.36 million | Q1 2017: $3.23 million | Q2 2017: $3.95 million | Q3 2017: $6.12 million | Q1 2018: $7.37 million | Q2 2018: $4.16 million | Q3 2018: $10.41 million | Q1 2019: $3.87 million | Q2 2019: $6.09 million | Q3 2019: $3.91 million | Q1 2020: $15.43 million | Q2 2020: $12.23 million | Q3 2020: $35.03 million | Q1 2021: $112.27 million | Q2 2021: $118.11 million | Q3 2021: $104.44 million | Q1 2022: $114.19 million | Q2 2022: $99.65 million | Q3 2022: $88.95 million | Q1 2023: $72.03 million | Q2 2023: $78.40 million | Q3 2023: $68.04 million | Q1 2024: $78.03 million | Q2 2024: $68.06 million | Q3 2024: $58.51 million | Q1 2025: $73.70 million | Q2 2025: $63.99 million | Q3 2025: $74.93 million.
- Historical annual values: Fiscal year 2025: $67.92 million | Fiscal year 2024: $72.02 million | Fiscal year 2023: $58.14 million | Fiscal year 2022: $80.00 million | Fiscal year 2021: $85.55 million | Fiscal year 2020: $28.15 million | Fiscal year 2019: $18.89 million | Fiscal year 2018: $8.93 million | Fiscal year 2017: $3.94 million | Fiscal year 2016: -$6.54 million | Fiscal year 2015: -$1.58 million | Fiscal year 2014: -$5.30 million | Fiscal year 2013: -$86.0 thousand | Fiscal year 2012: -$1.07 million | Fiscal year 2011: $193.1 thousand | Fiscal year 2011: $0.00.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: